Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
tumoral
|  
|  
| --over
|  
|
in thyroid adenocarcinoma | tumoral
|  
|  
|  
| gain of function
|
coactivation of NKX2-1 and NKX2–8 pathways in non-small-cell lung cancer resistant to standard cisplatin therapy and with poor prognosis | tumoral
|  
| amplification
|  
|  
|
and overexpression contribute to lung cancer cell proliferation rates and survival and implicate TITF1 as a lineage-specific oncogene in lung cancer | constitutional
| germinal mutation
|  
|  
|  
|
in neuroendocrine cell hyperplasia of infancy (NEHI) | tumoral
|  
|  
| --other
|  
|
ectopic expression of NKX2-1 in diffuse large B-cell lymphoma cells, representing the central player in an oncogenic regulative network compromising B-cell differentiation | |